The 2NN study - CD8 T cells
The 2NN study - CD8 T cells
The 2NN study - CD8 T cells
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Baseline characteristics<br />
NVP-od NVP-bd EFV NVP+EFV TOTAL<br />
n=220 n=387 n=400 n=209 n=1216<br />
sex, % male 63 61 64 68 63<br />
age, median<br />
(iqr)<br />
CD4 <strong>cells</strong>, <strong>cells</strong>/mm 3 median<br />
(iqr)<br />
HIV-1 RNA, log10 median<br />
(iqr)<br />
34<br />
(28-40)<br />
200<br />
(55-340)<br />
4.7<br />
(4.4-5.4)<br />
34<br />
(30-41)<br />
170<br />
(60-310)<br />
4.7<br />
(4.4-5.5)<br />
35<br />
(30-40)<br />
190<br />
(80-350)<br />
4.7<br />
(4.4-5.5)<br />
33<br />
(29-39)<br />
190<br />
(80-330)<br />
4.7<br />
(4.4-5.4)<br />
34<br />
(29-40)<br />
190<br />
(70-330)<br />
4.7<br />
(4.4-5.5)<br />
CDC-class C, % 20 22 21 18 21<br />
Risk behaviour, %<br />
heterosexual 56 61 56 53 57<br />
homosexual 26 26 29 35 29<br />
IVD 5 3 5 5 5<br />
other, unknown 13 10 10 7 9<br />
Hepatitis B, % 6.8 4.4 4.0 7.7 5.3<br />
Hepatitis C, % 10.0 9.0 10.0 9.1 9.5<br />
Frank van Leth 7
Change language